Questions with the most recent answer or edit.
Numbers first: 97.1% · a C8 column · tirzepatide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
What I am working with: lot-specific certificate · JEEP. I have read the primary source rather than the summary, which has left me with more questions. I understand…
What I am working with: 95.2% · mazdutide. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and…
The case in front of me: QST · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile. I understand the observation; what I do not understand is the…
Stated plainly: 99.1% · cagrilintide. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
Numbers first: Wuxi · Poland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which is…
I have been reading across the programmes and the A1c numbers do not line up in any way I can make sense of. SURPASS-2 reports tirzepatide lowering A1c by more than 2…
For reference: cystatin C · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The specifics, since they change the answer: oral semaglutide · minus 20 °C. Somebody stated this to me confidently and I would like to check it before repeating it.…
What I am working with: aggregation · 30 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like to define my thresholds before I have a result, for obvious…
The particulars: PeptideMeter · Qingdao Saber Technology. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
The case in front of me: GGT · four weeks · retatrutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
The particulars: STEP 4 · ecnoglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
The method section is present, which is unusual enough that I want to make use of it. This is one of those things that everyone repeats and nobody derives. This…
Setup, so nobody has to ask: WXT · Xi’an Mokemei Biotechnology. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
Conditions: HJ · QYB · Ireland. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the question is…
The particulars: PeptideMeter · Hunan Aslsen Technology. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
The case in front of me: PeptideMeter · 98.2%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
The case in front of me: a 27G needle · tirzepatide · 4 mg/mL. I would like the axes of comparison first and the recommendation second. I have tried the first option…
For reference: 96.4% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used to…
Numbers first: a 29G needle · retatrutide · 3.33 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Conditions: 40 mg · four weeks · early satiety. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…